Burrello et al reported a score that can predict primary aldosteronism without confirmatory testing. The authors are from the University of Torino, University of Bologna and Ludwig-Maximilians-Universitat Munchen.
PACT = Primary Aldosteronism Confirmatory Testing
Patient selection: suspected primary aldosteronism
Problems with confirmatory testing:
(1) time-consuming
(2) expensive
(3) no consensus on testing
Parameters:
(1) sex
(2) number of antihypertensive medications taken
(3) plasma renin activity (PRA) at screening in ng/mL per h
(4) serum aldosterone at screening in ng/dL
(5) lowest serum potassium in mmol/L
(6) organ damage
Parameter |
Finding |
Points |
sex |
female |
0 |
|
male |
2 |
antihypertensive drugs |
0 |
0 |
|
>= 1 |
1 |
PRA |
< 0.2 |
3 |
|
0.20 to 0.99 |
1 |
|
>= 1.0 |
0 |
serum aldosterone |
< 16.0 |
0 |
|
16.0 to 27.9 |
2 |
|
>= 28.0 |
4 |
lowest potassium |
< 3.7 |
4 |
|
3.7 to 3.9 |
2 |
|
>= 4.0 |
0 |
organ damage |
absent |
0 |
|
present |
2 |
total score =
= SUM(points for all of the parameters)
Interpretation:
• minimum score: 0
• maximum score: 16
PACT Score |
Interpretation |
Next Step |
< 5 |
primary aldosteronism not confirmed |
follow-up |
5 to 12 |
perform confirmatory test |
if confirmatory test positive then adrenal venous sample, else follow |
13 to 16 |
primary aldosteronism confirmed |
adrenal venous sampling |
Performance:
• The area under the ROC curve is 0.88.